{
    "root": "4635d706-5e3d-4817-bf04-802a20f72a70",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Chlorpromazine hydrochloride",
    "value": "20250312",
    "ingredients": [
        {
            "name": "CHLORPROMAZINE HYDROCHLORIDE",
            "code": "9WP59609J6"
        },
        {
            "name": "ASCORBIC ACID",
            "code": "PQ6CK8PD0R"
        },
        {
            "name": "SODIUM METABISULFITE",
            "code": "4VON5FNS3C"
        },
        {
            "name": "SODIUM SULFITE",
            "code": "VTK01UQK3G"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "treatment schizophrenia ; control nausea vomiting ; relief restlessness apprehension surgery ; acute intermittent porphyria ; adjunct treatment tetanus ; control manifestations manic type manic-depressive illness ; relief intractable hiccups ; treatment severe behavioral problems children ( 1 12 years age ) marked combativeness and/or explosive hyperexcitable behavior ( proportion immediate provocations ) , short-term treatment hyperactive children show excessive motor activity accompanying conduct disorders consisting following symptoms : impulsivity , difficulty sustaining attention , aggressivity , mood lability , poor frustration tolerance .",
    "contraindications": null,
    "warningsAndPrecautions": "chlorpromazine hydrochloride injection usp , 25 mg/ml 50 mg/2 ml ( 25 mg/ml ) , available following packages:1 ml single-dose ampule packaged 25s ( ndc 73043 048 25 ) 2 ml single-dose ampule packaged 25s ( ndc 73043 049 25 )",
    "adverseReactions": "patients known hypersensitivity phenothiazines . comatose states presence large amounts central nervous system depressants ( alcohol , barbiturates , narcotics , etc . ) .",
    "indications_original": "For the treatment of schizophrenia; to control nausea and vomiting; for\u00a0\n                     relief of restlessness and apprehension before surgery; for acute\u00a0 \n                     intermittent porphyria; as an adjunct in the treatment of tetanus; to\u00a0\n                     control the manifestations of the manic type of manic-depressive\u00a0 illness;\u00a0\n                     for relief of intractable hiccups; for the treatment of severe behavioral\u00a0\n                     problems in children (1 to 12 years of age) marked by\u00a0 combativeness\u00a0\n                     and/or explosive hyperexcitable behavior (out of proportion to\u00a0\n                     immediate provocations), and in the short-term treatment of hyperactive\u00a0\n                     children who show excessive motor activity with accompanying conduct\u00a0\n                     disorders consisting of some or all of the following\u00a0 symptoms: impulsivity,\u00a0\n                     difficulty sustaining attention, aggressivity, mood lability, and poor \n                     frustration tolerance.",
    "warningsAndPrecautions_original": "Chlorpromazine Hydrochloride Injection USP, 25 mg/mL and 50 mg/2 mL\u00a0(25 mg/mL), are available in the following packages:1 mL Single-Dose Ampule packaged in 25s (NDC 73043 048 25)2 mL Single-Dose Ampule packaged in 25s (NDC 73043 049 25)",
    "adverseReactions_original": "Do not use in patients with known hypersensitivity to phenothiazines.\n                  Do not use in comatose states or in the presence of large amounts of central nervous system depressants (alcohol, barbiturates, narcotics, etc.)."
}